Durata Therapeutics (FRA:DTA) Days Sales Outstanding : 1.74 (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Durata Therapeutics Days Sales Outstanding?

Durata Therapeutics's average Accounts Receivable for the three months ended in Sep. 2014 was €0.15 Mil. Durata Therapeutics's Revenue for the three months ended in Sep. 2014 was €7.82 Mil. Hence, Durata Therapeutics's Days Sales Outstanding for the three months ended in Sep. 2014 was 1.74.

The historical rank and industry rank for Durata Therapeutics's Days Sales Outstanding or its related term are showing as below:

FRA:DTA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 6.95
Current: 6.95

During the past 3 years, Durata Therapeutics's highest Days Sales Outstanding was 6.95. The lowest was 0.00. And the median was 0.00.

FRA:DTA's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.245 vs FRA:DTA: 6.95

Durata Therapeutics's Days Sales Outstanding increased from Sep. 2013 (0.00) to Sep. 2014 (1.74).

Durata Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Durata Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Durata Therapeutics Days Sales Outstanding Chart

Durata Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Days Sales Outstanding

Durata Therapeutics Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Days Sales Outstanding	Get a 7-Day Free Trial							-	-	-	-	1.74

Competitive Comparison of Durata Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Durata Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Durata Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Durata Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Durata Therapeutics's Days Sales Outstanding falls into.

Durata Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Durata Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2013 is calculated as

	Days Sales Outstanding (A: Dec. 2013 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2012 )	+	Accounts Receivable (A: Dec. 2013 ))	/	count )	/	Revenue (A: Dec. 2013 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Durata Therapeutics's Days Sales Outstanding for the quarter that ended in Sep. 2014 is calculated as:

	Days Sales Outstanding (Q: Sep. 2014 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2014 )	+	Accounts Receivable (A: Sep. 2014 ))	/	count )	/	Revenue (A: Sep. 2014 )	*	Days in Period
=	( (0	+	0.149)	/	1 )	/	7.823	*	365 / 4
=	0.149					/	7.823	*	365 / 4
=	1.74

Durata Therapeutics (FRA:DTA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Durata Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Durata Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Durata Therapeutics (FRA:DTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Durata Therapeutics Inc (FRA:DTA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.duratatherapeutics.com

Durata Therapeutics Inc was incorporated under the laws of the State of Delaware on November 4, 2009. The Company, along with its subsidiaries, is a development stage pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. The Company recently completed two global Phase 3 clinical trials with its lead product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing.

Durata Therapeutics (FRA:DTA) Headlines

No Headlines